Medical Doctor Program year 2025 Reported 2020–2025 Source: CMS Open Payments, 2026 publication

Brad Landrum

Undersea and Hyperbaric Medicine Murray, UT Medical Doctor

NPI 1356870620 CMS profile 3074316

5171 S Cottonwood St, Murray, UT 84107

Open in the dashboard

General payments

$1,535

57 records reported · program years 2020–2025

Research payments

$0

Paid to them · None reported · program years 2020–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Brad Landrum of Murray, UT is reported in the CMS Open Payments database as having received $1,535 across 57 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 71st percentile of Undersea and Hyperbaric Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $252 9
2024 General $437 22
2023 General $384 13
2022 General $135 5
2021 General $230 5
2020 General $97 3

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Brad Landrum
  • Undersea and Hyperbaric Medicine median
  • Middle half of Undersea and Hyperbaric Medicine
  • National median

In program year 2025, general payments to Brad Landrum were reported at $252. Among 121 Undersea and Hyperbaric Medicine profiles paid that year, the median was $208 and the middle half received between $52 and $518.

Show as a table
Year Brad Landrum Undersea and Hyperbaric Medicine median Middle half National median
2019 $0 $201 $85–$538 $163
2020 $97 $84 $31–$222 $114
2021 $230 $138 $52–$383 $132
2022 $135 $135 $51–$385 $149
2023 $384 $143 $75–$442 $160
2024 $437 $178 $80–$442 $164
2025 $252 $208 $52–$518 $169

Breakdown

Who paid General payments · program years 2020–2025
  1. Smith+Nephew, Inc. $300 10 payments
  2. Organogenesis Inc. $262 7 payments
  3. Urgo Medical North America, LLC $216 13 payments
  4. Solventum Corporation $108 5 payments
  5. KCI USA, Inc $90 4 payments
  6. Tactile Systems Technology Inc $76 1 payment
  7. Stryker Corporation $73 3 payments
  8. Medtronic, Inc. $72 1 payment
  9. TissueTech, Inc. $57 1 payment
  10. ProgenaCare Global, LLC $46 1 payment
  11. Other $236 11 payments

Every payment, record by record

What the payments were for General payments · program years 2020–2025
  1. Food and Beverage $1,535 57 payments
Products named General payments · program years 2020–2025
  1. Puraply $239 6 payments
  2. OASIS $203 6 payments
  3. ACTIV.A.C. $160 7 payments
  4. GRAFIX PL Other Advanced Wound Management $141 5 payments
  5. VASHE WOUND SOLUTION 250 ML (8.5 FL OZ) FLIP TOP CAP $111 7 payments
  6. GRAFIX PL Other Advanced Wound Management $94 2 payments
  7. URGOK2 $82 6 payments
  8. Flexitouch Plus $76 1 payment
  9. entre $76 1 payment
  10. HawkOne $72 1 payment
  11. Other $898 37 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 3 drugs

Part D claims

105

Median for Family Practice: 1,826

Drug cost

$1,190

Median for Family Practice: $120,094

Branded share of claims

0%

Median for Family Practice: 18.9%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Doxycycline Monohydrate Generic 81 $1,173
Metoprolol Tartrate Generic 12 $10
Meloxicam Generic 12 $7

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 105,120 Part D prescribers listed as Family Practice; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 20 billing codes

Paid by Medicare

$82,794

Medicare's payments for the services billed

Medicare patients

164

Average age 75

Services billed

1,914

72 women, 92 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 68%
Diabetes 57%
Chronic kidney disease 50%
Ischemic heart disease 49%
Heart failure 43%
Depression 37%
Atrial fibrillation 32%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

57 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Undersea and Hyperbaric Medicine in Utah

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record